| Acronym | Definition |
| AB | Able-bodied |
| AFF | Atypical Femoral Fracture |
| AIS | ASIA Impairment Scale |
| ASIA | American Spinal Cord Injury Association |
| BMD | Bone Mineral Density |
| CI | Confidence Interval |
| CPG | Clinical Practice Guideline |
| CTX-1 | C-terminal Cross-linking Telopeptide of Type I Collagen |
| DXA | Dual Energy X-ray Absorptiometry |
| DF | Distal Femur |
| FES | Functional Electrical Stimulation |
| FSH | Follicle-Stimulating Hormone |
| HR | Hazard Ratio |
| IGF-1 | Insulin-like Growth Factor 1 |
| IV | Intravenous |
| LH | Luteinizing Hormone |
| NMES | Neuromuscular Electrical Stimulation |
| NTX-1 | N-terminal Cross-linking Telopeptide of Type I Collagen |
| OC | Osteocalcin |
| ONJ | Osteonecrosis of the Jaw |
| OPG | Osteoprotegerin |
| ORIF | Open Reduction with Internal Fixation |
| PTH | Parathryroid Hormone |
| P1NP | Procollagen 1 Intact N-Terminal Propeptide |
| pQCT | Peripheral Quantitative Computed Tomography |
| PT | Proximal Tibia |
| PVA | Paralyzed Veterans of America |
| RANKL | Receptor Activator of Nuclear factor kappa-Β Ligand |
| SCI | Spinal Cord Injury |
| SCI/D | Spinal Cord Injury/Disease |
| ZA | Zolendronic Acid |